CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CERUS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$2.22+0.04 (+1.83%)
Close on Oct 19, 2026
- Market cap
- $445.25M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.69 (+45.10%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
CERUS CORP grew revenue 16.1% to $233.80M over fiscal 2025. Free cash flow was -$1.83M, down 153.4% from a year earlier.
Revenue
$233.80M
+16.1% vs. a year earlier
Operating income
-$1.62M
TTM Q2 2026
Free cash flow
-$1.83M
-153.4% vs. a year earlier
EPS, diluted
-$0.03
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $445.25M
- P/E ratio
- –
- Price to sales
- 1.90
- Price to book
- 6.36
- Dividend yield
- –
- Free cash flow yield
- -0.41%
Fundamentals
- Revenue
- $233.80M
- Net income
- -$6.78M
- EPS, diluted
- -$0.03
- Free cash flow
- -$1.83M
- Book value per share
- $0.35
- Diluted shares
- 201M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$1.62M
Net income
-$6.78M
EPS, diluted
-$0.03
Free cash flow
-$1.83M-153.4% YoY
Reported periodTrailing twelve months